Glucagon-like peptide 1 (GLP-1) could be a key factor driving the development of insulin-producing cells, according to in vitro data published in the journal Pancreas. The use of islet-cell ...

The company has a looming opportunity to grab the booming GLP-1 agonist market by the horns.